Prime Medicine 2026 shareholder votes and auditor ratified
Prime Medicine, Inc. held its 2026 annual stockholder meeting on June 5, 2026 via live webcast.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Prime Medicine, Inc. held its 2026 annual stockholder meeting on June 5, 2026 via live webcast. A quorum was established with 140,384,724 shares present or represented by proxy out of 180,615,889 shares of common stock entitled to vote as of the April 9, 2026 record date.
Stockholders elected Michael Kelly and David Schenkein, M.D. as Class I directors to serve until the 2029 annual meeting, with 107,059,058 and 87,522,409 votes "for," respectively. They also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 139,989,201 votes in favor.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares entitled to vote: 180,615,889 shares
Shares represented at meeting: 140,384,724 shares
Votes for Michael Kelly: 107,059,058 votes
+4 more
7 metrics
Shares entitled to vote
180,615,889 shares
Common stock outstanding and entitled to vote as of April 9, 2026
Shares represented at meeting
140,384,724 shares
Shares present or by proxy at 2026 annual meeting (quorum)
Votes for Michael Kelly
107,059,058 votes
Election as Class I director at 2026 annual meeting
Votes for David Schenkein, M.D.
87,522,409 votes
Election as Class I director at 2026 annual meeting
Votes for PwC ratification
139,989,201 votes
Ratification of PricewaterhouseCoopers LLP as 2026 auditor
Votes against PwC ratification
101,259 votes
Opposition to auditor ratification
Abstentions on PwC ratification
294,264 votes
Abstaining votes on auditor ratification proposal
Key Terms
Annual Meeting, quorum, broker non-votes, independent registered public accounting firm, +2 more
6 terms
Annual Meeting financial
"held its 2026 annual meeting of stockholders (the “Annual Meeting”) in a virtual meeting format"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
quorum financial
"140,384,724, thus establishing a quorum for the transaction of business"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
broker non-votes financial
"Michael Kelly | 107,059,058 | 3,047,945 | 30,277,721 broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
proxy statement financial
"Proxies were solicited pursuant to the Company’s definitive proxy statement (the “Proxy Statement”)"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Prime Medicine (PRME) approve at the 2026 annual meeting?
Stockholders elected two Class I directors and ratified the auditor. Michael Kelly and David Schenkein, M.D. were elected to serve until the 2029 annual meeting, and PricewaterhouseCoopers LLP was ratified as independent registered public accounting firm for fiscal year ending December 31, 2026.
Was there a quorum at Prime Medicine’s 2026 annual stockholder meeting?
Yes, a quorum was established with 140,384,724 shares present or represented by proxy. These shares of common stock were either present by remote communication at the virtual meeting or represented by valid proxies, satisfying quorum requirements for conducting business.
How did Prime Medicine (PRME) stockholders vote on director Michael Kelly in 2026?
Michael Kelly received 107,059,058 votes "for," 3,047,945 votes "withheld," and 30,277,721 broker non-votes. This support resulted in his election as a Class I director, with a term running until the company’s 2029 annual meeting of stockholders.
What were the 2026 vote results for director nominee David Schenkein at Prime Medicine?
David Schenkein, M.D. received 87,522,409 votes "for," 22,584,594 votes "withheld," and 30,277,721 broker non-votes. Based on these results, he was elected as a Class I director, to serve until Prime Medicine’s 2029 annual meeting of stockholders.
How did Prime Medicine (PRME) stockholders vote on ratifying PricewaterhouseCoopers in 2026?
Stockholders strongly ratified PricewaterhouseCoopers LLP as auditor with 139,989,201 votes "for." There were 101,259 votes "against" and 294,264 abstentions regarding its appointment as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Who signed the 2026 annual meeting report for Prime Medicine (PRME)?
The report was signed on behalf of Prime Medicine, Inc. by Allan Reine, M.D. He signed in his capacity as Chief Executive Officer, affirming that the registrant caused the report to be executed pursuant to the Securities Exchange Act of 1934 requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates